dc.contributor.authorGrinchuk, Oleg V.
dc.contributor.authorMotakis, Efthymios
dc.contributor.authorYenamandra, Surya Pavan
dc.contributor.authorOw, Ghim Siong
dc.contributor.authorJenjaroenpun, Piroon
dc.contributor.authorTang, Zhiqun
dc.contributor.authorYarmishyn, Aliaksandr A.
dc.contributor.authorIvshina, Anna V.
dc.contributor.authorKuznetsov, Vladimir A.
dc.date.accessioned2016-01-12T05:47:56Z
dc.date.available2016-01-12T05:47:56Z
dc.date.issued2015
dc.identifier.citationGrinchuk, O. V., Motakis, E., Yenamandra, S., Ow, G. S., Jenjaroenpun, P., Tang, Z., et al. (2015). Sense-antisense gene-pairs in breast cancer and associated pathological pathways. Oncotarget, 6(39), 42197-.en_US
dc.identifier.issn1949-2553en_US
dc.identifier.urihttp://hdl.handle.net/10220/39664
dc.description.abstractMore than 30% of human protein-coding genes form hereditary complex genome architectures composed of sense-antisense (SA) gene pairs (SAGPs) transcribing their RNAs from both strands of a given locus. Such architectures represent important novel components of genome complexity contributing to gene expression deregulation in cancer cells. Therefore, the architectures might be involved in cancer pathways and, in turn, be used for novel drug targets discovery. However, the global roles of SAGPs in cancer pathways has not been studied. Here we investigated SAGPs associated with breast cancer (BC)-related pathways using systems biology, prognostic survival and experimental methods. Gene expression analysis identified 73 BC-relevant SAGPs that are highly correlated in BC. Survival modelling and metadata analysis of the 1161 BC patients allowed us to develop a novel patient prognostic grouping method selecting the 12 survival-significant SAGPs. The qRT-PCR-validated 12-SAGP prognostic signature reproducibly stratified BC patients into low- and high-risk prognostic subgroups. The 1381 SAGP-defined differentially expressed genes common across three studied cohorts were identified. The functional enrichment analysis of these genes revealed the GABPA gene network, including BC-relevant SAGPs, specific gene sets involved in cell cycle, spliceosomal and proteasomal pathways. The co-regulatory function of GABPA in BC cells was supported using siRNA knockdown studies. Thus, we demonstrated SAGPs as the synergistically functional genome architectures interconnected with cancer-related pathways and associated with BC patient clinical outcomes. Taken together, SAGPs represent an important component of genome complexity which can be used to identify novel aspects of coordinated pathological gene networks in cancers.en_US
dc.description.sponsorshipASTAR (Agency for Sci., Tech. and Research, S’pore)en_US
dc.format.extent25 p.en_US
dc.language.isoenen_US
dc.relation.ispartofseriesOncotargeten_US
dc.rightsThis is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_US
dc.subjectComputer Science and Engineering
dc.titleSense-antisense gene-pairs in breast cancer and associated pathological pathwaysen_US
dc.typeJournal Article
dc.contributor.schoolSchool of Computer Engineeringen_US
dc.identifier.doihttp://dx.doi.org/10.18632/oncotarget.6255
dc.description.versionPublished versionen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record